commercialize OncoGenex lead

Related by string. * Commercialize . Commercializes . commercializes : commercializes innovative therapeutics . commercializes innovative biopharmaceuticals . successfully commercialize REOLYSIN / Oncogenex : OncoGenex Pharmaceuticals OGXI . PRNewswire FirstCall OncoGenex Pharmaceuticals . OncoGenex Pharmaceuticals Inc. / LEAs . LEAD : Operation Cast Lead . Albert Lea Minn. * *

Related by context. All words. (Click for frequent words.) 90 candidate custirsen 72 Roche SWX ROG 70 commercialize apixaban 70 compound KOS 70 Nycomed GmbH 69 commercialize Aganocides 69 Kosan dependence 69 commercialize Dimebon 68 Pancreate 68 commercialize SGN 67 Kosan motilin agonist 67 Quark Biotech 66 Taiho Pharmaceutical 66 commercialize deforolimus 66 cosmetic cosmeceutical products 66 PrevOnco 66 IMiDs ® 66 commercialize MDV# 66 XL# anticancer compounds 66 oral immunomodulatory 66 adrenergic regulation 66 Kosan epothilone program 66 RECOTHROM ® 66 Wellstat 65 Tibotec BVBA 65 commercialize conjugates consisting 65 targeted anticancer biopharmaceuticals 65 novel therapeutic antibodies 65 ospemifene 65 pharmacogenomic translational research 65 commercialize becocalcidiol patented 65 Vertex hepatitis C 65 Crofelemer budesonide foam 65 lixivaptan 65 candidate REP# 65 supplemental biologics 65 small molecule VR1 65 novel antibody therapeutics 65 commercialize Aganocide compounds 64 aerosolized AAT 64 BCR ABL inhibitors 64 InterfeRx TM 64 cladribine Cladribine Tablets 64 HepeX B 64 Daclizumab 64 staphylococcal vaccines 64 Idera Pharmaceuticals develops 64 intranasal insulin product 64 Anidulafungin 64 IMiDs R 64 CorMedix dependence 64 oral antiviral 64 mild vasodilator 64 Albuferon albinterferon alfa 2b 64 AVAX AC Vaccine 64 ImmunoGen TAP technology 64 InvaGen 64 SuperAntibody 64 OMAPRO ™ 64 Galderma SA 64 TRIOLEX HE# APOPTONE HE# 64 ZFP Therapeutics 64 small molecule glucokinase 64 molecular chaperone regulation 64 DP VPA 64 targeted radiotherapeutic 64 investigational oral anticoagulant 64 fusion enhancers 64 HepeX B TM 64 acne impetigo 64 Helsinn Healthcare 64 RTP #i 64 R sorafenib tablets 64 Lixivaptan 64 Jingxin Pharma 64 Ferring Pharmaceuticals privately 64 nitric oxide donating 64 Vitamin D analogue 64 ATL# [002] 64 SinuNase ™ 64 commercialize elagolix 63 commercialize XP# 63 progressive metastatic prostate 63 investigational pharmacologically unique 63 Nanobody 63 class mGluR5 inhibitor 63 Albugon 63 non nucleoside HCV 63 oral salmon calcitonin 63 IMiDs ® compound 63 sorafenib tablets 63 adenosine A2A 63 PDE# inhibitors 63 anti botulism antibody 63 commercialize CK # 63 rxRNA 63 Nippon Shinyaku 63 Pruvel TM 63 Initiates Enrollment 63 Dacetuzumab 63 TOPICA 63 Septin9 biomarker 63 OXIGON TM 63 HuMax TAC 63 LAS# [002] 63 Evoltra ® 63 DPX Survivac 63 MSCRAMM ® 63 commercializes VIVITROL ® 63 International SRL BLS 63 commercialize teduglutide outside 63 GlycArt 63 Pharmion GmbH wholly owned 63 acetonide FA 63 Alder Biopharmaceuticals Inc. 63 ADCC enhanced 63 topical PTH #-# 63 therapeutic monoclonal antibody 63 Currently RegeneRx 63 EHT AGN 63 Aradigm Logo 63 successfully commercialize Iluvien 63 JAK inhibitor 63 Aviptadil 63 Fovea Pharmaceuticals 63 anti CD3 monoclonal 63 Lipocine 63 NASDAQ CGEN announced 63 Budesonide foam crofelemer 63 VentiRx 63 XL# XL# XL# XL# 63 Vaccinex 63 Hythiam researches develops 63 Celulas Genetica purchased 63 commercialize dimebon latrepirdine 63 commercialize microRNA therapeutics 63 Nutra Pharma wholly owned 63 VaxImmune 63 Nanobody R 63 PEGylated docetaxel 62 Galenea 62 Aganocide ® 62 valtorcitabine 62 HepDirect R 62 Mipomersen 62 Campath ® 62 Roche SWX ROG.VX 62 Silodosin 62 Cutanea 62 THR beta agonist 62 personalized cellular immunotherapy 62 PORxin TM platforms 62 oral dihydropyrimidine dehydrogenase DPD 62 commercializes innovative physiological 62 gastro intestinal inflammation 62 JOULFERON 62 5 lipoxygenase activating 62 Unit Dose Budesonide 62 HuCAL antibodies 62 psoriasis rheumatoid arthritis 62 virus HCV protease inhibitor 62 Syntonix 62 developing Zerenex ferric 62 OncoVex 62 enhanced skin permeation 62 candidates Azedra TM 62 OMP #R# 62 Provectus Pharmaceuticals specializes 62 delivery polymer matrix 62 Idera Pharmaceuticals 62 MKC# MKC# PP 62 Zenapax 62 Beyond Advair 62 Melior Discovery 62 gets USFDA nod 62 oral NKTR 62 Bayer HealthCare Onyx Pharmaceuticals 62 Archexin 62 Merck Serono division 62 Cardium Therapeutics TM 62 optical biosensors 62 compound INCB# 62 skeletal sarcomere activators 62 adult multipotent stem 62 Empatic ™ 62 Davanat 62 commercialize deforolimus ARIAD 62 MAGE A3 ASCI 62 acyclovir Lauriad R 62 Atripla combines 62 TRACON Pharmaceuticals 62 Captisol ® 62 International LAB Pharma 62 staphylococcal vaccine 62 metaglidasen 62 Handok Pharmaceuticals 62 HCV antiviral 62 BioNumerik 62 Ercole Biotech 62 promotes MERREM ® 62 Pharma Merck Serono 62 Novartis NVS Snapshot Report 62 APR Labtec 62 small molecule thrombopoietin 62 Taiho Pharmaceutical Co. 62 mitogen activated ERK kinase 62 AcryMed technologies 62 vemurafenib 62 POTELLIGENT ® Technology 62 Inc. www.micromet inc.com 62 TBC# 62 Zacharon 62 therapeutic monoclonal antibodies 62 GeneraMedix Inc. 62 TELINTRA R 62 ZEFTERA TM Zevtera TM 62 antisense drug 62 Gastrotech 62 Oasmia 62 Alfacell proprietary ribonuclease 62 Trastuzumab DM1 62 Teplizumab 62 infectious diseases autoimmune 62 Idenix Novartis 62 Oral Suspension USP 62 NuMimetic TM 62 IMPDH inhibitor 62 Aflibercept 62 mGluR5 PAM 62 polymer conjugate technology 62 Annamycin 62 Spiegelmer 61 faropenem 61 humanized therapeutic 61 HCV RNA polymerase 61 capabilities Icagen 61 YONDELIS R 61 manufactures EBI 61 Maribavir 61 Onalta 61 NASDAQ PHRM 61 Boehringer Ingelheim CHDI Novartis 61 v Nastech 61 PHX# 61 Ostabolin C TM 61 novel immunomodulatory 61 PI3K/Akt pathway inhibitor 61 dihydrochloride Tablets 61 IMiDs 61 AB OMXS BINV 61 Pertuzumab 61 Oral NKTR 61 MicroDose 61 Xcytrin R 61 semi synthetic lipoglycopeptide 61 Generx TM 61 delivers fluocinolone acetonide FA 61 novel antiviral therapeutics 61 Namenda Memantine HCl 61 Inc. OTCBB IRBS 61 memantine HCl 61 dutogliptin 61 commercializing Loramyc ® 61 MERREM 61 PF # [002] 61 kidney urologic 61 oncolytic virus therapies 61 outlicensed 61 StromaCel Inc. 61 P#X# antagonist 61 SGLT Inhibitors 61 Transfluor 61 Veronate R 61 commercialize Hematide 61 Additionally Soligenix 61 Cellgate Inc. 61 INxin TM 61 AAG geldanamycin analog 61 TRANSDUR ™ 61 OMJPI 61 pralatrexate injection folate analogue 61 PORxin TM 61 Nexavar ® 61 POTELLIGENT R 61 Panzem R NCD 61 Dyax phage display 61 Micromet proprietary BiTE 61 recurrent metastatic ovarian cancer 61 CysDisplay R 61 HGS ETR1 mapatumumab 61 Alligator Bioscience AB 61 oral ghrelin agonist 61 Teikoku Pharma USA 61 Sepracor licensees 61 pafuramidine maleate 61 Solzira ™ 61 Teikoku Seiyaku Co. 61 diabetes irritable bowel 61 subsidiaries visit http:/www.apricusbio.com 61 Kuvan R 61 methylnaltrexone bromide 61 Holding AG ROG.VX 61 IG HCR ;) CO 61 oral taxane 61 elvucitabine 61 Targeted Chemotherapy 61 Cephalon GlaxoSmithKline 61 POTELLIGENT R Technology 61 4SC AG ISIN DE# 61 oral prodrug 61 triggers apoptosis programmed 61 volociximab 61 oral dual endothelin 61 PER.C6 r 61 Juvantia 61 Fovea Pharmaceuticals subsidiary 61 Cadila Pharmaceuticals named 61 IAP inhibitor 61 Innovive Pharmaceuticals 61 Initiates Clinical Trial 61 HELSINN 61 immunotherapeutic vaccine 61 dimebon latrepirdine 61 EP #R 61 novel peptides 61 OTC Bulletin Board TENF 61 LymphoStat B TM 61 Enzo Therapeutics 61 NewBridge Pharmaceuticals 61 RhuDex R 61 Maxy G# 61 NEBIDO VANTAS SUPPRELIN LA 61 Hematide ™ 61 Acetylon 61 Potelligent Technology 61 SIX RO ROG 61 CDP# 61 novel VDA molecule 61 Pazopanib 61 CYT# potent vascular disrupting 61 AVEO integrates proprietary 61 label Lipofen R 61 2A receptor agonist 61 PDE4 inhibitor 61 Tyzeka Sebivo 61 Alnylam RNAi 61 Nasdaq IDIX biopharmaceutical 61 Spiegelmer ® 61 toenail onychomycosis 61 taxane derivative 61 vii Cubist ability 61 FOLOTYN ® 61 LHRH antagonist 61 ELADUR ™ 61 treat nicotine addiction 61 please visit http:/www.vandapharma.com 61 molecular imaging radiopharmaceutical 61 EpiTherapeutics 61 Announces Tentative Approval 61 DEB# 61 SPL# Gel vaginal microbicide 61 Dyax logo 61 KAI Pharmaceuticals 61 AcryMed Incorporated 61 Panzem NCD 61 using VIAdel TM 61 elotuzumab 61 developing TB4 61 Lisofylline LSF 60 Locked Nucleic Acid 60 Iluvien ® 60 JAK2 Inhibitor 60 Syncria albiglutide 60 GVAX ® 60 TOCOSOL Camptothecin 60 InterfeRx 60 ASONEP 60 Prochymal TM 60 KAI Pharmaceuticals Inc. 60 midstage clinical 60 LX# LX# LX# 60 YONDELIS 60 SUTENT ® 60 Canvaxin 60 oral Janus kinase 60 AERx iDMS 60 Files IND 60 reformulates existing FDA 60 beta 1a 60 gepirone ER 60 bendamustine HCl 60 RenaZorb TM 60 BioGeneriX AG 60 Teriflunomide 60 tiapamil 60 M# rationally 60 Sigma Tau SpA 60 HCV polymerase 60 erlotinib Tarceva R 60 Civacir 60 Hsp# Inhibitor 60 Myocet 60 selective estrogen receptor modulator 60 TransPharma 60 Rexahn licensees 60 Gentamicin Surgical Implant 60 Nextoy LLC used 60 Initiates Clinical 60 Fresenius Biotech 60 CYT# vascular disrupting 60 proprietary intranasal insulin 60 sanofi aventis SNY 60 Oglemilast 60 Pharmalink 60 Ostarine ™ 60 Nalmefene 60 mertansine 60 Marinomed 60 RNA antagonists 60 RhuDex ® 60 Mochida Pharmaceutical Co. 60 specific CCR9 antagonist 60 Personalized Immunotherapy 60 tivozanib AV 60 Allos retains exclusive 60 HEPLISAV TM hepatitis B 60 Crucell PER.C6 60 Validus Pharmaceuticals 60 Cx# [002] 60 Pancreas Cancer Vaccine 60 IV meropenem 60 selective androgen receptor modulators 60 vapreotide acetate 60 liposomal formulation 60 NS5B polymerase 60 Spirogen 60 Cerashield ™ 60 epothilone 60 Belimumab 60 Adnectin 60 Biolipox 60 Xeloda ® 60 Vertex retains 60 LymphoStat B belimumab 60 Archemix Corp. 60 delta gamma agonist 60 TRANSDUR ® 60 Roche Trimeris 60 BioFocus DPI Galapagos 60 refractory chronic lymphocytic 60 Taisho Pharmaceuticals 60 romazarit 60 non nucleoside inhibitor 60 AFREZZA TM 60 glucokinase activator 60 Amigal TM 60 Alantos 60 R#/MEM 60 commercialized DURECT 60 Oncolys 60 topical anti infective 60 Adamis Pharmaceuticals 60 Syndax Pharmaceuticals Inc. 60 Initiates Phase II 60 ImmunoGen maytansinoid TAP 60 lead molecular radiotherapeutic 60 CellCentric 60 Portola Pharmaceuticals 60 Roche SIX RO 60 Perforomist TM formoterol fumarate 60 Immunotope 60 DARA logo 60 alvespimycin 60 OvaRex R 60 selective immunoproteasome inhibitor 60 Begins Dosing 60 developing Bicifadine serotonin 60 NovaBay Aganocide compounds 60 novel emulsion formulation 60 BioGeneriX 60 Creabilis Therapeutics 60 Exelixis compounds 60 Sequella 60 novel synthetic PEGylated 60 CCR9 antagonist 60 Lovaza TM 60 Crucell PER.C6 ® 60 either acutely decompensated 60 Euroscreen 60 Peyronie disease Frozen Shoulder 60 pradefovir 60 nasal calcitonin product 60 Prednisporin 60 Novolimus 60 Astellas Deutschland GmbH 60 novel anti infective 60 delta opioid receptor 60 sorafenib tablets small 60 Naglazyme R 60 Surfaxin LS 60 Selective Electrochemical Tumor Ablation 60 evaluating tivozanib 60 next generation URAT1 60 synthetic retinoid 60 ThermoDox R 60 Chipscreen 60 Nasdaq CGEN 60 MPH AMEX 60 proven DuraSite ® 60 Aurora kinase inhibitor 60 BioSante Pharmaceuticals Announces 60 multivalency 60 Endotis 60 Submits Biologics License Application 60 trastuzumab Herceptin R 60 PrevOnco ™ 60 EC Cysteamine 60 Zor Pharmaceuticals 59 EOquin TM phase 59 STEDESA 59 Allovectin 7 59 R MSCRAMM 59 BioLineRx BL 59 AKT inhibitor 59 Adentri 59 GSK '# 59 including eniluracil ADH 59 Biovitrum AB 59 Inotek Pharmaceuticals Corporation 59 PEGylated interferon 59 Initiates Dosing 59 proprietary MSCRAMM ® 59 Alinia 59 zolpidem tartrate sublingual tablet 59 purinergic receptors P#X# 59 mesylate 59 NYSE Amex AEN 59 Excaliard 59 TaiGen 59 LentiVector 59 Urocidin TM 59 peptidic compound 59 recombinant biopharmaceutical 59 Dynepo TM 59 telomerase therapeutic 59 Helsinn Healthcare SA 59 mitiglinide 59 ASONEP ™ 59 AdVac ® 59 www.3dsyndication.com 59 cardio metabolic diseases 59 FoldRx Pharmaceuticals Inc. 59 GLPG# 59 candidate TNFerade biologic 59 Tibotec Pharmaceuticals Ltd. 59 OTCBB PYTO 59 albiglutide 59 PurEffect TM anti 59 ATL/TV# 59 Aloprim TM allopurinol sodium 59 proprietary PEGylation 59 GPR# agonist 59 Cutanea Life Sciences 59 Pruvel ™ 59 Peginterferon alfa 2b 59 small molecule Hedgehog 59 Muraglitazar 59 soft tabs levitra 59 Zion Asher Menashe 59 IV APAP 59 XL# XL# XL# 59 PNP inhibitor 59 Prodarsan R 59 MedGenesis 59 AstraZeneca PLC AZN AZN.LN 59 Completes Patient Enrollment 59 biobetter 59 Ube Industries Ltd. 59 Paris IPN Euronext 59 HYVISC ® treatment 59 Aileron Therapeutics 59 Onalta TM 59 Relivar 59 candidate KRN# 59 CCR5 inhibitor 59 vinorelbine tartrate 59 ATL# [001] 59 Aeolus Pharmaceuticals Announces 59 Antibody Drug Conjugate 59 Critical Therapeutics Zyflo 59 Ganciclovir 59 Lupuzor 59 Glufosfamide 59 Receives Fast Track 59 nicotinic alpha 7 59 ART# 59 Prism Pharmaceuticals 59 Avila Therapeutics 59 BioInvent 59 bepotastine besilate 59 Saladax Biomedical 59 RECOTHROM R 59 IgG1 monoclonal antibody 59 TBC M4 59 ESTRASORB ® 59 Meda STO MEDAA 59 Laboratorio Teuto Brasileiro SA 59 AstraZeneca MedImmune 59 BioSante licensees 59 Posiphen TM 59 Solazed 59 Pegloticase 59 lipid nanoparticle 59 Addrenex 59 TYZEKA 59 Agensys subsidiary 59 Panzem R 59 Adenoscan R 59 CCR5 mAb 59 Metabasis dependence 59 Roche OTC RHHBY 59 GRNOPC1 contains 59 plus prednisone prednisolone 59 Selzentry Celsentri 59 LEVADEX ™ 59 Vytorin combines 59 Knopp Neurosciences 59 PsychoGenics 59 Aplidin 59 Zemiva TM 59 Clovis Oncology 59 relapsed leukemia 59 CB2 selective 59 Tykerb lapatinib 59 Merck OSI Pharmaceuticals 59 Potelligent TM Technology 59 developing Zerenex TM 59 ® bortezomib 59 BioSyent Pharma 59 Other ImmunoGen collaborative 59 reslizumab 59 dirucotide MBP# 59 includes AstraZeneca Accolate 59 Scancell 59 CK # skeletal muscle 59 Medicis Pediatrics Inc. 59 Modrenal R 59 Hexvix ® 59 FOLFOX6 chemotherapy regimen 59 candidate deforolimus 59 Merck Sante sas 59 anticancer therapeutics 59 agonistic human 59 neuronal nicotinic receptor NNR 59 EGFr humanized monoclonal antibody 59 treats acute lymphoblastic 59 Pierre Fabre SA 59 LentiVector technology 59 MOVIPREP R 59 ROXRO 59 HemoGenix 59 trastuzumab DM1 T DM1 59 intravesical infusion therapy 59 Meets Primary Endpoint 59 orally administered inhibitor 59 R#/MEM # 59 allosteric modulator PAM 59 NS5b 59 SMA Indústria Química SA 59 cathepsin K inhibitor 59 investigational protease inhibitor 59 orally disintegrating 59 utilizes InSite Vision 59 Synerx Pharma 59 CPL Biologicals 59 Argatroban 59 Phusion Laboratories 59 Elvitegravir 59 Horizant ™ 59 Graffinity Pharmaceuticals 59 JAK inhibitors 59 Addrenex Pharmaceuticals 59 eligen 59 PSN# [001] 59 markets HP Acthar 59 tenofovir disoproxil fumarate Viread 59 selective orally bioavailable 59 Amplimexon 59 Additionally Zcom 59 MKC# MT 59 AVEO Pharmaceuticals NASDAQ 59 OMP #M# 59 Diep Tran MD 59 Locked Nucleic Acid LNA 59 Through Glycoscience R 59 Vernalis plc 59 fipamezole 59 Sebivo 59 oral opioid modulator 59 SYCREST 59 Staccato nicotine technology 59 NU# direct 59 OTC ZEGERID 59 Pyridorin 59 Cenomed 59 5 HT4 59 * olmesartan medoxomil 59 adenosine injection 59 ImQuest 59 Biocon Biopharmaceuticals 59 Pentad TM 59 Nanotherapeutics 59 KNS # 59 Epitomics 59 Nitazoxanide 59 CEROVIVE NXY 59 ADP receptor antagonist 59 candidate volociximab 59 Proellex TM 59 ATG Fresenius S 59 Pagoclone 59 Another Novartis Menveo 59 investigational integrase inhibitor 59 AdhTAP 59 Enhanze 59 small molecule macrocyclic 59 leading oral taxane 59 Behcet uveitis 59 Aganocide 59 introduced NEUGENE 59 RANK Ligand inhibitor 59 recombinant PSMA vaccine 59 Noscira 59 Santen Pharmaceutical 59 Potelligent TM 59 Sphingomab TM 59 cMET 59 itraconazole Sporanox 59 selective A2A adenosine receptor 59 Oxytrex TM 59 Ikaria Holdings Inc. 59 receptor tyrosine kinase inhibitor 59 Vitrasert R 59 fluorinated carbohydrate mimics 59 Tragara Pharmaceuticals Inc. 59 Granted Orphan Drug 59 using Crucell PER.C6 59 defensin mimetic antibiotic 59 Vitaxin 59 DOV Pharmaceutical 59 Inc. AMEX YMI 59 naloxol derivative 59 Norgine BV 59 polymerase inhibitor 59 stage antibody MT# 59 Initiates Phase III 59 OGX Maranhão 59 Zenyaku Kogyo 59 Anticalins R 59 acadesine 59 patented probiotic bacteria 59 selective androgen receptor modulator 59 Pepducin 59 dermatology therapies 59 lintuzumab SGN 58 Xenon Pharmaceuticals 58 TRACON Pharmaceuticals Inc. 58 ASONEP TM 58 hepatitis B immune globulin 58 Tibotec Therapeutics division 58 commercialize JX 58 Kissei Pharmaceutical 58 multi kinase inhibitor 58 promising anticancer 58 Teijin Pharma 58 XL# XL# 58 mark LabWindows 58 TM pralatrexate injection 58 Orapred ODT 58 forodesine hydrochloride 58 RONDEL ™ 58 Inc. http:/www.QuigleyPharma.com conducts 58 proprietary MSCRAMM protein 58 AXIRON 58 Oracea TM 58 sulfonylhydrazine class 58 neurology immunology 58 Synerx 58 Fortical R 58 Liprotamase 58 product platforms AZX# 58 superparamagnetic iron oxide nanoparticles 58 Zygogen 58 developing Surfactant Replacement 58 developing adecatumumab 58 CrystalGenomics 58 Mg Uk 58 attach auristatin 58 Campto 58 siRNA therapeutics 58 5 HT2A inverse 58 Nanobody ® 58 IMPACS R 58 Fibrosis Foundation Therapeutics 58 GlaxoSmithKline MedImmune 58 AZX# 58 Aganocide TM 58 CHDI Foundation 58 optimal dosing regimens 58 Oral Calcitonin 58 OTCBB URGP specialty 58 Isis antisense 58 Nuon Therapeutics 58 Inc. AMEX LIV 58 Euronext SAN 58 novel chimeric natriuretic 58 Japanese Encephalitis Vaccine 58 Cetrorelix 58 histone deacetylase HDAC inhibitors 58 Kyowa Hakko Kogyo 58 GATTEX TM 58 Boehringer Ingelheim MedImmune 58 Lupin Pharmaceuticals 58 HTS assay 58 UltiMAb 58 commercializing oxidized glutathione 58 Asentar TM 58 NeoGenesis 58 Receives Approvable Letter 58 Rapinyl 58 patented DepoVax TM 58 Altera Nebulizer System 58 Glaxo Wellcome PLC 58 NTDDS 58 Quark Biotech Inc. 58 MSCRAMM R 58 platforms GVAX 58 Glenmark Pharmaceuticals Limited 58 vitreoretinal disorders 58 Xanthus Pharmaceuticals Inc. 58 ELADUR TM 58 synthetic siRNA 58 Launches Generic Version 58 GeneraMedix 58 D aspartate NMDA receptor 58 Thrombin topical Recombinant 58 MEDAREX 58 Junovan TM 58 muscarinic receptor agonist 58 Vegenics 58 ionotropic glutamate receptor antagonists 58 INSPIRE Trial Phase III 58 synthetic ligand affinity 58 certain protein tyrosine 58 Biotica 58 Inc. www.prometic.com 58 eligen R technology 58 ZaBeCor 58 iv Nastech 58 About Positron Positron 58 migraine headaches neuropathic pain 58 KaloBios 58 CEQ# 58 liver resection surgeries 58 Predictive medicine 58 highly selective adenosine 58 TRANSDUR Bupivacaine 58 human IgG1 monoclonal 58 sirtuin modulators 58 addressing idiopathic pulmonary 58 Altair Therapeutics 58 Curaxin 58 targeted immunotherapies 58 EnVivo Pharmaceuticals 58 SOLVAY PHARMACEUTICALS 58 Captisol 58 palonosetron hydrochloride Injection Dacogen 58 Enanta Pharmaceuticals 58 therapeutic peptide 58 proprietary buccal 58 oral PTH 58 Azmacort R 58 Arno Therapeutics 58 targeting miR 58 inhibitor PRO 58 HIV integrase inhibitor 58 Novosom 58 sapacitabine CYC# 58 luliconazole 58 MTP inhibitor 58 topically applied SEPA 58 Talabostat 58 Quark Pharmaceuticals 58 GTC NASDAQ GTCB 58 Fc fusion protein 58 Somatuline Depot 58 oral talactoferrin 58 TIMERx 58 Etubics 58 KuDOS 58 ZALBIN 58 Viagra Soft Cialis Soft 58 CCR5 receptor antagonist 58 Phenomix Corporation 58 Combivir Kivexa 58 Pirespa 58 AdVac 58 Cephalon GlaxoSmithKline Organon 58 Commercialization Agreement 58 HCV NS5B polymerase 58 biotherapeutic drugs 58 Idun Pharmaceuticals 58 TRO# 58 MEDA AB publ 58 Ecallantide 58 Pandel R 58 LEAD Therapeutics 58 CIMZIA r 58 Neuromed Pharmaceuticals 58 Proteo 58 lipoglycopeptide 58 Cara Therapeutics 58 Ono Pharmaceutical 58 anticoagulant reversing agent 58 PharmFilm ® 58 delay bone metastases 58 CIMYM 58 Amira Pharmaceuticals 58 topical antifungal product 58 Piramed 58 commercialize AzaSite 58 Japanese drugmaker Daiichi 58 include Healive TM 58 betrixaban 58 TFChem 58 TKPHF 58 JAK2 inhibitor 58 NEUGENE antisense 58 patentable compounds 58 VIBEX MTX 58 Prednisporin TM 58 product platforms GVAX 58 Marillion Pharmaceuticals 58 HuLuc# 58 Genentech sanofi aventis 58 TransVax ™ 58 Kaketsuken 58 Biogen Genentech 58 DepoVax TM 58 CD4 monoclonal antibody 58 exclusive sublicense 58 Laquinimod 58 inhibit metastasis 58 CYP#A# isoenzyme 58 docetaxel Taxotere R 58 custirsen sodium 58 brand ciclesonide HFA 58 rhMBL 58 Orphan Therapeutics 58 thiazolides 58 intranasal formulation 58 immunotherapeutic approaches 58 C3 Jian 58 miRNA therapeutics 58 liposomal delivery 58 IMC #F# 58 R memantine HCl 58 ocrelizumab 58 Angiocept 58 IV Busulfex 58 pain palliation 58 Panzem 58 Medarex UltiMAb Human 58 Cellzome 58 KellBenx 58 Reata Pharmaceuticals 58 HepDirect prodrug 58 unique alkylating agent 58 E2F Decoy 58 Anchor Therapeutics 58 peripherally acting 58 Alseres Cethrin 58 engineered proteases 58 Sudhir Agrawal D.Phil 58 DsiRNA pharmaceuticals 58 MolecularBreeding 58 Piperacillin 58 Neugene 58 isoform selective 58 Duromist ™ 58 Neurimmune 58 MorphoSys Galapagos 58 Cerimon 58 cMET inhibitor 58 Novacort 58 generation antisense 58 Argenta Discovery 58 genetically engineered recombinant protein 58 sodium glucose transporter

Back to home page